West Announces The Commercial Launch Of The B.safe Syringe Safety System Technology Platform
LIONVILLE, Pa., Sept. 11, 2012 /PRNewswire/ -- West (NYSE: WST), a leading global developer and manufacturer of components and systems for injectable drug delivery, announces the commercial introduction of its B.safe™ syringe safety system. West acquired the IP and rights to this system in 2011 and has completed the product development and first phase of commercial scale-up at its safety systems manufacturing center in France. Significant scale-up to high-volume manufacturing will be achieved in the first half of 2013, in order to meet market demands.
(Logo: http://photos.prnewswire.com/prnh/20120904/NE65950LOGO )
The system is designed to help protect against needlestick injury when using a prefilled syringe and will complement West's portfolio of prefilled syringe offerings and technologies. West's portfolio includes the NovaGuard™ passive needle system for Luer Lock syringes and the eris™ system, of which more than 1 billion units have been manufactured and used in the market with exceptional performance in the hands of healthcare workers and patients.
"We are delighted to reach this significant milestone and be in a position to offer our customers a globally available safety system, leveraging our established expertise around prefilled syringes and needle safety," said Glenn Thorpe, Vice President, Strategic Market Development, Syringe Systems. "With the completion of the steps necessary to offer this system commercially, we are in position to meet growing market demand in this area, and are pleased to have already signed our first commercial agreement and commenced shipments."
Click here for more information on the B.safe syringe safety system technology. About West West's innovative system, device and component solutions help improve the safety and administration of injectable drugs. West's proprietary materials science, formulation research and manufacturing technologies advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics and vaccines. Sales in 2011 totaled US$1.2 billion. West supports its customers from sales, manufacturing, customer support and research and development locations in North and South America, Europe, Asia and Australia. Global headquarters are in Lionville, Pa., USA. Visit West online at http://www.westpharma.com. Follow West on Twitter: http://www.twitter.com/WestPharma. B.safe ™ is a registered trademark of Tech Group Europe, Ltd., a subsidiary of West Pharmaceutical Services, Inc. NovaGuard ™ is a trademark of West Pharmaceutical Services, Inc. in the United States and other jurisdictions eris™ is a trademark of Tech Group Europe, Ltd., a subsidiary of West Pharmaceutical Services, Inc. Media Contact: Kristin Villiotte Schwartz MSL(781) 684-0770 westpharma@schwartzmsl.comSelect the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
